Prof Amos Burke

MBChB PhD MA(Cantab) FRCPEdin FRCPCH

Amos Burke is a Professor of Paediatric Oncology at the University of Birmingham and an Honorary Consultant Paediatric Oncologist at Birmingham Women and Children’s Hospital. He is the Director of the Cancer Research UK Clinical Trials Unit (CRCTU) and leads research strategy for one of the UK’s largest and internationally important clinical trials units that deliver a trial portfolio over a wide range of cancers occurring in children, young people and adults.

His research is focused on childhood non-Hodgkin lymphoma. Currently, he is Chief Investigator for the innovative platform trial Glo-BNHL for children with relapsed and refractory mature B-cell Non-Hodgkin Lymphoma.

Projects

Prof Amos Burke

is working on

Articles featuring

Prof Amos Burke

Read our latest news

Meet more people

Dev Note:
This slider will be replaced by the cards above in the published site.
Dev Note:
This slider will be replaced by the cards above in the published site.
Dev Note:
This slider will be replaced by the cards above in the published site.
Dev Note:
This slider will be replaced by the cards above in the published site.
Dev Note:
This slider will be replaced by the cards above in the published site.

Get Involved

CoLaborate with us to accelerate childhood cancer research and innovation

Patient Stories
Collaboration
Innovation Accelerators
Survivorship and Living Well
Future Leaders
Safer Therapies
Next-Generation Therapies
Children’s Cancer CoLab and Maddie Riewoldt’s Vision Clinician-Researcher Fellowship
Future Leaders
Innovation Accelerators
Survivorship and Living Well
Safer Therapies
Next-Generation Therapies